FDA
-
-
-
-
-
-
-
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
-
-
-
-
-
-
-
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
-
-
-
-
-
-
-
Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update
-
-
-
-
-
-
-
Miromatrix Reports First Quarter 2022 Results and Provides Corporate Update
-
-
-
-
-
-
-
Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure
-
-
-
-
324,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

